17,967 Shares in Xylem Inc. $XYL Bought by Figure 8 Investment Strategies LLC

Figure 8 Investment Strategies LLC acquired a new position in Xylem Inc. (NYSE:XYLFree Report) during the second quarter, according to the company in its most recent filing with the SEC. The fund acquired 17,967 shares of the industrial products company’s stock, valued at approximately $2,124,000. Xylem makes up 1.8% of Figure 8 Investment Strategies LLC’s holdings, making the stock its 20th biggest holding.

Several other large investors also recently modified their holdings of XYL. J. Stern & Co. LLP increased its position in shares of Xylem by 12,326.6% during the fourth quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock worth $6,189,132,000 after acquiring an additional 45,082,435 shares during the last quarter. BlackRock Inc. purchased a new position in Xylem in the second quarter valued at about $2,959,730,000. Bank of New York Mellon Corp acquired a new stake in Xylem during the 2nd quarter valued at approximately $552,313,000. Norges Bank acquired a new stake in Xylem during the 4th quarter valued at approximately $361,012,000. Finally, Deutsche Bank AG purchased a new stake in Xylem during the 2nd quarter worth approximately $223,165,000. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Xylem Stock Performance

Shares of XYL opened at $113.98 on Wednesday. The business’s fifty day moving average price is $117.69 and its 200 day moving average price is $120.18. Xylem Inc. has a 12-month low of $105.29 and a 12-month high of $154.27. The stock has a market capitalization of $26.61 billion, a PE ratio of 27.14, a price-to-earnings-growth ratio of 1.66 and a beta of 1.02. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.61 and a quick ratio of 1.24.

Xylem (NYSE:XYLGet Free Report) last released its earnings results on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share for the quarter, beating the consensus estimate of $1.34 by $0.12. The firm had revenue of $2.34 billion during the quarter, compared to analyst estimates of $2.34 billion. Xylem had a net margin of 11.15% and a return on equity of 11.77%. The firm’s revenue for the quarter was up 1.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.26 earnings per share. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. Equities research analysts forecast that Xylem Inc. will post 5.67 EPS for the current year.

Xylem Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 24th. Investors of record on Thursday, August 27th will be given a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date of this dividend is Thursday, August 27th. Xylem’s dividend payout ratio is currently 40.95%.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on XYL shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Xylem in a research note on Wednesday, August 5th. Barclays lifted their price target on shares of Xylem from $154.00 to $159.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 29th. CLSA upgraded shares of Xylem to a “hold” rating in a research note on Thursday, June 25th. Mizuho raised their price objective on shares of Xylem from $124.00 to $130.00 and gave the stock a “neutral” rating in a report on Wednesday, July 29th. Finally, Stifel Nicolaus boosted their target price on shares of Xylem from $157.00 to $160.00 and gave the stock a “buy” rating in a research report on Wednesday, July 29th. Nine investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $154.23.

Check Out Our Latest Analysis on Xylem

About Xylem

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Further Reading

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.